Rinske Drost

Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i> -Mutated Mouse Mammary Tumors

Janneke E. Jaspers, Ariena Kersbergen, Ute Boon et al. · Cancer Discovery · 2012 · 515 citations · Full text

Medicine, Oncology, Pharmacology +17

Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin

Bastiaan Evers, Rinske Drost, Eva Schut et al. · Clinical Cancer Research · 2008 · 334 citations · Full text

Medicine, Oncology, Pharmacology +16

BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance

Rinske Drost, Peter Bouwman, Sven Rottenberg et al. · Cancer Cell · 2011 · 266 citations · Full text

Medicine, Cancer Biology, Oncology +15

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1

Rinske Drost, Kiranjit K. Dhillon, Hanneke van der Gulden et al. · Journal of Clinical Investigation · 2016 · 141 citations · Full text

Life Sciences, Genetics, Oncology +16

A High-Throughput Functional Complementation Assay for Classification of <i>BRCA1</i> Missense Variants

Peter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden et al. · Cancer Discovery · 2013 · 137 citations

Life Sciences, Genetics, Molecular Genetics +15